Drug intelligence / Profile preview

Optimel Manuka

Development stage
Unknown
Lead developer
Melcare Biomedical
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Optimel Manuka is an over-the-counter ophthalmic solution formulated for the temporary relief of burning and irritation due to dryness of the eye. Its primary active ingredient is glycerin (0.2%), which acts as a lubricant. The formulation also contains pharmaceutical-grade honey derived from Leptospermum species (commonly known as manuka honey), sodium benzoate, sodium chloride, and water[1][5][7]. The product leverages the natural antibacterial properties of manuka honey—specifically its methylglyoxal content—to reduce bacterial colonization on the eyelid margin, thereby helping to stabilize tear film quality and reduce inflammation associated with dry eye disease and meibomian gland dysfunction[2][4][8]. Clinical studies have shown that regular application can significantly reduce colony-forming units (CFUs) on eyelids in patients with dry eye or meibomian gland disease, potentially lowering susceptibility to bacterial conjunctivitis and keratitis while improving symptoms such as sore or irritated eyes[2][4]. Developed by Melcare Biomedical in Australia since 2015, it is available in both drop (daytime) and gel (nighttime) formulations[6].

Brand names
Optimel ManukaOptimel Manuka+Optimel Manuka+ Dry Eye DropsOptimel Manuka+ Forte Eye Gel

Beyond the preview

Go deeper on Optimel Manuka.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optimel Manuka.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call